Literature DB >> 4029017

Temocillin pharmacokinetics in normal and impaired renal function.

D Höffler, P Koeppe.   

Abstract

In 18 healthy volunteers and 18 patients with varying degrees of impaired renal function, the plasma concentrations after intravenous administration of temocillin 0.5, 1, and 2g were determined. Another group of 6 patients received temocillin 0.5 g intramuscularly. Surprisingly, it was found that with higher doses, the plasma concentrations, and consequently the area under the plasma concentration/time curve (AUC), did not increase proportionately. Instead, the renal and, to a greater extent, the total clearance of temocillin increased. The plasma concentrations in patients with impaired renal function were clearly higher than in the subjects with normal renal function. Dose-reduction factors were derived which allowed the determination of the dosing regimen necessary to achieve approximately the same high plasma concentrations (and the same AUCs) in patients with impaired renal function as in healthy subjects. However, these dose-reduction factors could only be determined for certain doses because of the specific behaviour of temocillin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4029017     DOI: 10.2165/00003495-198500295-00028

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  9 in total

1.  [Recent nephrologic examination methods. A critical review].

Authors:  D Höffler; P Fiegel
Journal:  Dtsch Med Wochenschr       Date:  1972-06-09       Impact factor: 0.628

2.  [Dosage of Cefoperazone in Normal and Restricted Renal Function (author's transl].

Authors:  C Piper; P Koeppe; D Höffler
Journal:  MMW Munch Med Wochenschr       Date:  1982-03-12

3.  Temocillin compared to ampicillin against Haemophilus influenzae and with other penicillins against intestinal aerobic Gram-negative rods.

Authors:  H Y Chen; J D Williams
Journal:  J Antimicrob Chemother       Date:  1982-10       Impact factor: 5.790

4.  [Pharmacokinetics of carbenicillin in high dosage (author's transl)].

Authors:  D Höffler; P Koeppe; P Fiegel; D Hölzel; R Ringelmann; U Goeschel; W R Palmer
Journal:  Dtsch Med Wochenschr       Date:  1974-03-01       Impact factor: 0.628

5.  Temocillin, in-vitro activity and the pharmacokinetics and tissue penetration in healthy volunteers.

Authors:  R M Brown; R Wise; J M Andrews
Journal:  J Antimicrob Chemother       Date:  1982-10       Impact factor: 5.790

6.  Cerebral toxicity of penicillins in relation to their hydrophobic character.

Authors:  T R Weihrauch; H Köhler; D Höffler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

7.  BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humans.

Authors:  B Slocombe; M J Basker; P H Bentley; J P Clayton; M Cole; K R Comber; R A Dixon; R A Edmondson; D Jackson; D J Merrikin; R Sutherland
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

8.  Comparative in vitro study of temocillin (BRL 17421), a new penicillin.

Authors:  R Bolivar; S S Weaver; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

9.  Pharmacokinetics of Cefmenoxime in normal and impaired renal function.

Authors:  D Höffler; P Koeppe
Journal:  Arzneimittelforschung       Date:  1983
  9 in total
  1 in total

Review 1.  Pharmacokinetics and Pharmacodynamics of Temocillin.

Authors:  Kevin Alexandre; Bruno Fantin
Journal:  Clin Pharmacokinet       Date:  2018-03       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.